Results 101 to 110 of about 224,309 (314)

Immunotherapy of Peritoneal Carcinomatosis with Catumaxomab [PDF]

open access: yesOnkologie, 2011
Peritonectomy and cytoreductive surgery with or without HIPEC (hyperthermic intraperitoneal chemotherapy) has been performed with some impressive results in patients with PC in slow growing GI tumours [6]. Patients with PC secondary to gastric cancer have been shown to have a median survival of up to 12 months with complete cytoreduction [7].
openaire   +3 more sources

Ascitic ovarian cancer is an adequate preclinical model of carcinomatosis to study intraperitoneal chemoperfusion treatment

open access: yesСибирский онкологический журнал, 2019
To study the mechanisms underlying the effects of intraperitoneal chemoperfusion and to develop the optimal chemoperfusion regimen, an animal model of peritoneal carcinomatosis closely resembles a human model of peritoneal carcinomatosis is required.
G. S. Kireeva   +6 more
doaj   +1 more source

Deep Transfer Learning Methods for Colon Cancer Classification in Confocal Laser Microscopy Images

open access: yes, 2019
Purpose: The gold standard for colorectal cancer metastases detection in the peritoneum is histological evaluation of a removed tissue sample. For feedback during interventions, real-time in-vivo imaging with confocal laser microscopy has been proposed ...
Bengs, Marcel   +6 more
core   +1 more source

Mid‐regional pro‐adrenomedullin: A rapid sepsis biomarker for diagnosing spontaneous bacterial peritonitis in cirrhosis

open access: yesEuropean Journal of Clinical Investigation, Volume 55, Issue 6, June 2025.
The study design included a derivation cohort of 236 visits and a validation cohort of 85 visits. Patients with cirrhosis and ascitic decompensation were evaluated and categorized based on the presence or absence of bacteriologically confirmed‐spontaneous bacterial peritonitis (BC‐SBP).
Abderrahim Oussalah   +17 more
wiley   +1 more source

Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer [PDF]

open access: yes, 2016
The small GTPase Rab25 has been functionally linked to tumour progression and aggressiveness in ovarian cancer and promotes invasion in three-dimensional environments.
Chalmers, Anthony J.   +3 more
core   +1 more source

Surrogate Markers of Intestinal Permeability, Bacterial Translocation and Gut–Vascular Barrier Damage Across Stages of Cirrhosis

open access: yesLiver International, Volume 45, Issue 6, June 2025.
ABSTRACT Background and Aims Portal hypertension, gut barrier dysfunction, and pathological bacterial translocation are hallmarks of cirrhosis driving complications. As measuring gut barrier function is demanding, surrogate markers have been proposed, but their intercorrelation and applicability across different stages of advanced liver disease ...
Frederic Haedge   +9 more
wiley   +1 more source

Autofluorescent Imaging in Patients With Peritoneal Carcinomatosis [PDF]

open access: yesSurgical Innovation, 2013
Background and objectives. Autofluorescence imaging (AFI) is mainly used to detect (pre)cancerous colorectal and pulmonal lesions. This is the first report establishing the feasibility of AFI in patients with peritoneal carcinomatosis (PC). Methods. This is a prospective analysis of 10 patients undergoing conventional white-light laparoscopy (WL) and ...
von Breitenbuch, Philipp   +6 more
openaire   +4 more sources

Peritoneal carcinomatosis from non-gynecologic malignancies [PDF]

open access: bronze, 2000
Babak Sadeghi   +14 more
openalex   +2 more sources

The Degree of Extramural Spread of T3 Colon Cancer as a Prognostic Factor: Another Appeal to the American Joint Committee on Cancer

open access: yesCancer Medicine, Volume 14, Issue 9, May 2025.
ABSTRACT Background The pT3 category of colon cancer staging is heterogeneous and has significant prognostic value. However, this is not reflected in the current TNM staging system. The objective of this work is to determine whether the extent of infiltration beyond the muscularis propria of pT3 colon carcinoma is an independent risk factor for worse ...
Beatriz Arencibia‐Pérez   +7 more
wiley   +1 more source

Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer

open access: yesBritish Journal of Cancer, 2018
Peritoneal carcinomatosis (PC) represents an unfavourable prognostic factor for patients with gastric cancer (GC). Intraperitoneal treatment with the bispecific and trifunctional antibody catumaxomab (EpCAM, CD3), in addition to systemic chemotherapy ...
M. Knödler   +14 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy